Group treatment of children and adolescent
319 results
1 - 100
Drug interventions for the treatment of obesity in children and adolescents- Omega‐3 fatty acid supplementation for depression in children and adolescents
- Interventions for improving communication with children and adolescents about a family member's cancer
- Interventions for self‐harm in children and adolescents
- Pharmacotherapy for trichotillomania
- Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents: Cochrane systematic review
- Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer
- Surgery for the treatment of obesity in children and adolescents
- Drugs for the acute treatment of migraine in children and adolescents
- Interventions for self‐harm in children and adolescents
- Antidepressants for functional abdominal pain disorders in children and adolescents
- Fluoride gels for preventing dental caries in children and adolescents
- Interventions for improving communication with children and adolescents about their cancer
- Fluoride varnishes for preventing dental caries in children and adolescents: Cochrane systematic review
- Community‐based interventions for improving mental health in refugee children and adolescents in high‐income countries
- Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents
- Tricyclic drugs for depression in children and adolescents
- Precision nutrition‐based interventions for the management of obesity in children and adolescents up to the age of 19 years
- Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents
- Psychological therapies for children and adolescents exposed to trauma
- Interventions for treating obesity in children: Cochrane systematic review
- Pharmacotherapy for anxiety disorders in children and adolescents: Cochrane systematic review
- Beginning reading interventions for children and adolescents with intellectual disability
- Extracorporeal photopheresis versus alternative treatment for chronic graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents
- Physical activity and education about physical activity for chronic musculoskeletal pain in children and adolescents
- Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight
- Aripiprazole for autism spectrum disorders (ASD)
- E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions
- Inhaled steroids with and without regular formoterol for asthma: serious adverse events
- Preoperative analgesics for additional pain relief in children and adolescents having dental treatment
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Extracorporeal photopheresis versus standard treatment for acute graft‐versus‐host disease after haematopoietic stem cell transplantation in children and adolescents
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for cancer‐related pain in children and adolescents
- Gut microbiome‐based interventions for the management of obesity in children and adolescents aged up to 19 years
- Interventions to prevent or cease electronic cigarette use in children and adolescents
- Interventions for promoting participation in shared decision‐making for children and adolescents with cystic fibrosis
- Opioids for cancer‐related pain in children and adolescents
- Chlorhexidine treatment for the prevention of dental caries in children and adolescents: Cochrane systematic review
- Interventions for treating femoral shaft fractures in children and adolescents: Cochrane systematic review
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Digital health, technology‐driven or technology‐assisted interventions for the management of obesity in children and adolescents
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy
- Orthodontic treatment for distalising upper first molars in children and adolescents: Cochrane systematic review
- Cognitive behavioural therapy for anxiety disorders in children and adolescents
- Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused: Cochrane systematic review
- Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents: Cochrane systematic review
- Intervention for dysarthria associated with acquired brain injury in children and adolescents: Cochrane systematic review
- Fluoride mouthrinses for preventing dental caries in children and adolescents
- Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions
- Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents
- Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury
- Interventions for the restorative care of amelogenesis imperfecta in children and adolescents
- Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents
- Opioids for chronic non‐cancer pain in children and adolescents
- Paracetamol (acetaminophen) for chronic non‐cancer pain in children and adolescents
- Acupuncture for slowing the progression of myopia in children and adolescents: Cochrane systematic review
- Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents
- Acyclovir for treating varicella in otherwise healthy children and adolescents
- Psychosocial interventions for recurrent abdominal pain in childhood
- Antidepressants for chronic non‐cancer pain in children and adolescents
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma
- Addition of anti‐leukotriene agents to inhaled corticosteroids in children with persistent asthma
- Interventions to prevent obesity in children aged 12 to 18 years old
- Antiepileptic drugs for chronic non‐cancer pain in children and adolescents
- Interventions for treating ankle fractures in children
- Recombinant growth hormone for children and adolescents with Turner syndrome: Cochrane systematic review
- Cognitive behavioural therapy for anxiety disorders in children and adolescents